ATE414762T1 - Herstellung kultivierter menschlicher mastzellen und basophilen zur hochdurchsatz-entdeckung kleiner arzneistoffmoleküle - Google Patents

Herstellung kultivierter menschlicher mastzellen und basophilen zur hochdurchsatz-entdeckung kleiner arzneistoffmoleküle

Info

Publication number
ATE414762T1
ATE414762T1 AT02763580T AT02763580T ATE414762T1 AT E414762 T1 ATE414762 T1 AT E414762T1 AT 02763580 T AT02763580 T AT 02763580T AT 02763580 T AT02763580 T AT 02763580T AT E414762 T1 ATE414762 T1 AT E414762T1
Authority
AT
Austria
Prior art keywords
cells
mast cells
screening
methods
basophils
Prior art date
Application number
AT02763580T
Other languages
English (en)
Inventor
Alexander Rossi
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE414762T1 publication Critical patent/ATE414762T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0642—Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02763580T 2001-08-31 2002-08-29 Herstellung kultivierter menschlicher mastzellen und basophilen zur hochdurchsatz-entdeckung kleiner arzneistoffmoleküle ATE414762T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31672301P 2001-08-31 2001-08-31
US10/053,355 US7070996B2 (en) 2001-08-31 2001-11-08 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery

Publications (1)

Publication Number Publication Date
ATE414762T1 true ATE414762T1 (de) 2008-12-15

Family

ID=26731760

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02763580T ATE414762T1 (de) 2001-08-31 2002-08-29 Herstellung kultivierter menschlicher mastzellen und basophilen zur hochdurchsatz-entdeckung kleiner arzneistoffmoleküle

Country Status (8)

Country Link
US (2) US7070996B2 (de)
EP (1) EP1427812B1 (de)
JP (1) JP4388372B2 (de)
AT (1) ATE414762T1 (de)
AU (1) AU2002327583A1 (de)
DE (1) DE60229960D1 (de)
DK (1) DK1427812T3 (de)
WO (1) WO2003020896A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029697B2 (en) 2001-02-14 2006-04-18 Northwestern University Controlled surface-associated delivery of genes and oligonucleotides
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
WO2004015389A2 (en) * 2002-08-09 2004-02-19 Rigel Pharmaceuticals, Inc. Methods of identifying compouds that modulate igg mediated mast cell activation
WO2005012294A1 (en) * 2003-07-30 2005-02-10 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
JP2007536936A (ja) 2004-05-14 2007-12-20 ベクトン・ディキンソン・アンド・カンパニー 幹細胞集団および使用方法
EP1781637A1 (de) * 2004-06-29 2007-05-09 Rigel Pharmaceuticals, Inc. 2-substituierte chinolinverbindungen und deren verwendungen als inhibitoren der ige-rezeptor-signalkaskade
CN1993460A (zh) * 2004-07-12 2007-07-04 索林集团意大利有限公司 用于培养人细胞的装置和方法
US7659280B2 (en) * 2006-02-17 2010-02-09 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
US20100015615A1 (en) * 2008-04-30 2010-01-21 Sloan-Kettering Institute For Cancer Research Identification and Isolation of Adult Stem Cells and Related Methods of Use
US9096829B2 (en) 2009-03-12 2015-08-04 University Of South Florida Human mast cell line and uses thereof
JP5804280B2 (ja) * 2009-09-08 2015-11-04 国立大学法人京都大学 多能性幹細胞からの肥満細胞の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2052035A (en) * 1932-03-21 1936-08-25 Thomas R Potter Combination game board and accessories
US4559310A (en) * 1983-05-20 1985-12-17 Dana Farber Cancer Institute Assay methods and systems utilizing mast cell clones
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US6190655B1 (en) 1993-12-03 2001-02-20 Immunex Corporation Methods of using Flt-3 ligand for exogenous gene transfer
FR2728584A1 (fr) * 1994-12-22 1996-06-28 Centre Nat Rech Scient Procede de transfert de gene dans des cellules activees a partir d'un etat de repos
US6261841B1 (en) 1999-06-25 2001-07-17 The Board Of Trustees Of Northwestern University Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells

Also Published As

Publication number Publication date
EP1427812B1 (de) 2008-11-19
WO2003020896A3 (en) 2003-10-30
US20030077824A1 (en) 2003-04-24
EP1427812A4 (de) 2005-04-27
WO2003020896A9 (en) 2003-12-18
JP4388372B2 (ja) 2009-12-24
US20070015280A1 (en) 2007-01-18
DK1427812T3 (da) 2009-03-16
DE60229960D1 (de) 2009-01-02
AU2002327583A1 (en) 2003-03-18
JP2005501552A (ja) 2005-01-20
WO2003020896A2 (en) 2003-03-13
EP1427812A2 (de) 2004-06-16
US7070996B2 (en) 2006-07-04

Similar Documents

Publication Publication Date Title
Corsini et al. Human organoids: New strategies and methods for analyzing human development and disease
ATE414762T1 (de) Herstellung kultivierter menschlicher mastzellen und basophilen zur hochdurchsatz-entdeckung kleiner arzneistoffmoleküle
Barakat et al. Stable X chromosome reactivation in female human induced pluripotent stem cells
UA81398C2 (en) Keratinocytes which may be used as biologically active substances for the treatment of wounds
GB0312481D0 (en) Antibodies
DE69632949D1 (de) Die aktivierung von rezeptoren durch gas6
NZ514951A (en) Recombinant protein production in a cultured human cell
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
IL196893A (en) Cell or cell line of vertebrate-containing amino acids trna synthase
WO2005020924A3 (en) A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method
DE69920747D1 (de) Methode zur herstellung von rekombinanten zellen
ATE287945T1 (de) Herstellung und verwendung von dendritischen zellen
IL151746A0 (en) Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
NO20031141L (no) Nye forbindelser
DE60044087D1 (de) Verfahren und mittels zur manipulierung der expression des uncoupling proteins
EP1272669A4 (de) Durchmusterung von bibliotheken exprimierter dna in filamentösen pilzen mit hoher durchsatzrate
Wilson-Sánchez et al. From genes to shape in leaf development and evolution
UY28558A1 (es) Proteína
AR043862A1 (es) Procedimiento para la obtencion de estirpes celulares de mastocitos a partir de tejidos de cerdo y procedimiento para la produccion de moleculas de tipo de la heparina
Dipali et al. Self‐Organizing Ovarian Somatic Organoids Preserve Cellular Heterogeneity and Reveal Cellular Contributions to Ovarian Aging
ATE144791T1 (de) Innerhalb des alpha-locus gelegenes t-zell- rezeptor-gen und dna-konstruktionen
EP3467112A3 (de) Verfahren zur transfektion von nukleinsäure in lebende zellen
BR0316822A (pt) Recombinação de dna especìfica da sequência em células eucarióticas
PT1242653E (pt) Celulas electroquimicas para electrolisador com tecnica de elementos individuais
WO2004016743A3 (en) Culturing anaplasma

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1427812

Country of ref document: EP